Additional Positive Interim Results from Nanoform’s Clinical Study
Insider information Nanoform Finland Plc February 24, 2021 08:10 a.m.…
2021 Controlled & Modified Drug Release Virtual Summit
Our Chief Technology Officer, Niklas Sandler, will be presenting at…
Invitation to presentation of Nanoform’s year-end report for 2020 on February 26, 2021
Press release Nanoform Finland Plc February 12, 2021 11:00 a.m.…
Nanoform and Herantis sign Biologics Proof of Concept Agreement
Press release Nanoform Finland Plc February 9th, 2021 08:10 a.m.…
Nanoform’s Clinical Study Indicates Positive Interim Results
Insider information Nanoform Finland Plc January 22nd, 2021 at 08.10…
Finnish Foundation for Share Promotion and Nasdaq Helsinki has chosen Nanoform as the company of the month (article in Finnish)
Helsinki, Finland – Finnish Foundation for Share Promotion (Pörssisäätiö/Börsstiftelsen) and…